XML 24 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Equity - USD ($)
$ in Millions
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Loss
Unearned ESOP Shares [Member]
Dow Inc. [Member]
Retained Earnings [Member]
The Dow Chemical Company
The Dow Chemical Company
Common Stock [Member]
The Dow Chemical Company
Additional Paid-in Capital [Member]
The Dow Chemical Company
Retained Earnings [Member]
The Dow Chemical Company
Accumulated Other Comprehensive Loss
The Dow Chemical Company
Unearned ESOP Shares [Member]
The Dow Chemical Company
Noncontrolling Interests
Total Equity, Beginning at Dec. 31, 2020   $ 8 $ 7,595 $ 16,361 $ (10,855) $ (49)     $ 0 $ 7,603 $ 16,300 $ (10,855) $ (49)  
Stock Issued                   211        
Stock-based compensation and allocation of ESOP shares     182     25       182     25  
Net income available for The Dow Chemical Company common stockholder $ 4,552     4,575             4,576      
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees             $ (2,361)              
Other       18             (18)      
Other comprehensive income 1,190       1,190     $ 1,190       1,190    
Total Equity, Ending at Sep. 30, 2021 17,028 8 7,988 19,357 (9,665) (24)   17,393 0 7,996 18,497 (9,665) (24) $ 589
Total Equity, Beginning at Jun. 30, 2021   8 7,898 18,200 (9,676) (32)     0 7,906 17,745 (9,676) (32)  
Stock Issued                   11        
Stock-based compensation and allocation of ESOP shares     79     8       79     8  
Net income available for The Dow Chemical Company common stockholder 1,675     1,683             1,679      
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees             (919)              
Other       8             (8)      
Other comprehensive income 11       11     11       11    
Total Equity, Ending at Sep. 30, 2021 17,028 8 7,988 19,357 (9,665) (24)   17,393 0 7,996 18,497 (9,665) (24) 589
The Dow Chemical Company’s stockholders’ equity 16,439             16,804            
The Dow Chemical Company’s stockholders’ equity 18,165             18,455            
Total Equity, Beginning at Dec. 31, 2021 18,739 8 8,151 20,623 (8,977) (15)   19,029 0 8,159 19,288 (8,977) (15)  
Stock Issued                   99        
Stock-based compensation and allocation of ESOP shares     198     15       198     15  
Net income available for The Dow Chemical Company common stockholder 3,948     3,969             3,975      
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees             (3,755)              
Other       13             (17)      
Other comprehensive income (605)       (605)     (605)       (605)    
Total Equity, Ending at Sep. 30, 2022 18,629 8 8,396 23,068 (9,582) 0   18,877 0 8,456 19,491 (9,582) 0 512
Total Equity, Beginning at Jun. 30, 2022   8 8,343 22,827 (9,204) 0     0 8,375 20,049 (9,204) 0  
Stock Issued                   2        
Stock-based compensation and allocation of ESOP shares     79     0       79     0  
Net income available for The Dow Chemical Company common stockholder 735     739             747      
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees             $ (1,301)              
Other       5             (4)      
Other comprehensive income (378)       (378)     (378)       (378)    
Total Equity, Ending at Sep. 30, 2022 18,629 $ 8 $ 8,396 $ 23,068 $ (9,582) $ 0   18,877 $ 0 $ 8,456 $ 19,491 $ (9,582) $ 0 $ 512
The Dow Chemical Company’s stockholders’ equity $ 18,117             $ 18,365